M&A Volume May Shift from Hospice to Home Health

Though many expect a hospice M&A rebound in 2024, the scales are tipping in favor of home health companies among buyers. Generally, signs point to heightened buyer activity this year, particularly among private equity as interest rates start to come down. After 2023’s slump, PE firms have been sitting on more than $800 million in dry powder, according to data shared with Hospice News by The Braff Group. Interest in hospice remains high, but the home health’s profile is rising faster in today’s market, according to Joel Rhodes, partner at the M&A advisory firm Triavo Health.

Read the full article: M&A Volume May Shift from Hospice to Home Health //

Source: https://hospicenews.com/2024/03/26/ma-volume-may-shift-from-hospice-to-home-health/

Leave a Comment

Your email address will not be published.

Scroll to Top